leisure time -WSS

leisure time

author：focus 2025-09-30 01:14:33 - browse：158

AI skin cancer detector, dermasensor. -- health tech coverage from STAT — Around 5 million skin cancers are diagnosed each year in the United States. Skin cancer is common, but it’s also not that deadly when caught early. Courtesy DermaSensor

The Food and Drug Administration cleared an AI-powered device for detecting skin cancer on Wednesday, giving primary care physicians a new way to evaluate troubling skin spots.

Around 5 million skin cancers are diagnosed each year in the United States. Skin cancer is common, but most types are not that deadly when caught early.

The device, developed by a small company called DermaSensor, is handheld and uses light to examine suspicious moles on a cellular level. It will be marketed specifically for primary care physicians to use in routine check-ups in patients aged 40 and above.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： United colonoscopy coverage change 'may cost lives,' doctors say

WSS

Americans' trust in science, scientist continues decline: Report

Medical records are filled with copy

Jerome Adams on the need for new antivirals for Covid

Patients' immediate access to test results puts radiologists in a bind

Medical leaders decry Supreme Court decision on affirmative action

Guidelines to prevent youth baseball injuries need more muscle

knowledge

leisure time

focus

In Memoriam: Notable people who died in 2023

Medical leaders decry Supreme Court decision on affirmative action

Sports medicine is finally prioritizing gender equality

ChatGPT in medicine: STAT answers readers' burning questions

State Dept. review finds Biden bears some blame for Afghanistan failures

Continuity nursing helped my family in our darkest PICU moments

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Medicare details structure of new drug price negotiation program

Sports medicine is finally prioritizing gender equality

What causes an itch? Researchers may have solved the mystery

focus

FDA approves world's first CRISPR

Jerome Adams on the need for new antivirals for Covid

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

Medical leaders decry Supreme Court decision on affirmative action

Medical records are filled with copy

Apple is now the first public company to be valued at $3 trillion

hotspot

leisure time

knowledge

hotspot